{"id":123546,"date":"2021-11-30T17:47:58","date_gmt":"2021-11-30T17:47:58","guid":{"rendered":"https:\/\/fin2me.com\/?p=123546"},"modified":"2021-11-30T17:47:58","modified_gmt":"2021-11-30T17:47:58","slug":"stocks-making-the-biggest-moves-midday-american-airlines-gap-moderna-and-more","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-midday-american-airlines-gap-moderna-and-more\/","title":{"rendered":"Stocks making the biggest moves midday: American Airlines, Gap, Moderna and more"},"content":{"rendered":"
Check out the companies making headlines in midday trading Tuesday.<\/em><\/p>\n American Airlines, Norwegian Cruise Line \u2014 Travel stocks retreated, as investors continued to weigh the risks from the Covid omicron variant. American Airlines shares retreated more than 4%, Norwegian Cruise Line lost more than 6%, Wynn Resorts fell roughly 5%, and Airbnb dipped 4.9%.<\/p>\n Gap, Under Armour \u2014 Retail stock were under pressure after Cyber Monday online sales dropped 1.4% from last year, falling for the first time ever, according to Adobe Analytics. However, Adobe believes customers are spreading out their shopping this year and expects the entire holiday season will post record-breaking online sales growth. Gap fell more than 6%, Under Armour retreated about 5%, and Tommy Hilfiger-parent PVH Corp lost more than 4%.<\/p>\n Regeneron Pharmaceuticals \u2014 Regeneron shares fell more than 2% after the company said its Covid-19 antibody drugs could be less effective against the omicron Covid variant.\u00a0The company said mutations in the variant suggest "there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity."<\/p>\n Moderna,\u00a0Pfizer \u2014 Shares of vaccine makers were in focus after Moderna CEO Stephane Bancel told The Financial Times he\u00a0expects existing vaccines to be less effective\u00a0against the omicron variant. Researchers are still studying the new variant's reaction to prior immunity, and Oxford University said there is\u00a0no evidence yet\u00a0that current vaccines will not protect against severe disease from omicron. Moderna shares fell more than 6%. BioNTech shares fell more than 5%. Pfizer shares gained roughly 2%. Novavax shares added more than 2%.<\/p>\n Dollar Tree \u2014 The discount retailer's stock slid 4.5% after Goldman Sachs downgraded Dollar Tree to neutral from buy. The firm said the company's operational improvements were priced in, and that Dollar Tree would struggle with foot traffic issues in the year ahead.<\/p>\n Solaredge \u2014 The clean energy stock shed 6.3% after Morgan Stanley downgraded it to equal-weight. The investment firm said in a note to clients that Solaredge's shares may be fully valued after a recent hot streak.<\/p>\n Meta Platforms\u00a0\u2014 Facebook-parent Meta's shares fell more than 3% after the U.K. competition watchdog said the company should sell the GIF-sharing platform\u00a0Giphy, which Facebook acquired last year. The regulator said the deal could harm social media users and U.K. advertisers. Meta has said it disagrees with the decision is considering an appeal.<\/p>\n Beyond Meat,\u00a0Oatly \u2014 Shares of Beyond Meat and Oatly retreated roughly than 6% and 7%, respectively, after HSBC initiated coverage of the protein stocks at a reduce rating. "Given the prospect of heightened competition, the growth we forecast will be insufficient for many participants to achieve their lofty growth ambitions," the firm said.<\/p>\n Twitter, Square \u2014 Shares of Twitter and Square retreated more than 5% and 2%, respectively. The moves come a day after Jack Dorsey announced he is stepping down as CEO of Twitter while staying on as chief executive at Square.\u00a0Bank of America upgraded\u00a0Square to neutral from underperform and reiterate a buy rating for Twitter.<\/p>\n \u2014 CNBC's Jesse Pound and Tanaya Macheel contributed reporting<\/em><\/p>\n